Alport syndrome: Difference between revisions
No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 4: | Line 4: | ||
Name = Alport syndrome | | Name = Alport syndrome | | ||
ICD10 = {{ICD10|Q|87|8|q|80}} | | ICD10 = {{ICD10|Q|87|8|q|80}} | | ||
ICD9 = | ICD9 = | | ||
ICDO = | | ICDO = | | ||
Image = | | Image = | | ||
Caption = | | Caption = | | ||
OMIM = 301050 | | OMIM = 301050 | | ||
OMIM_mult = {{OMIM2|104200}} {{OMIM2|203780 | OMIM_mult = {{OMIM2|104200}} {{OMIM2|203780}}| | ||
MedlinePlus = 000504 | | MedlinePlus = 000504 | | ||
DiseasesDB = 454 | | DiseasesDB = 454 | | ||
Line 36: | Line 36: | ||
''This article incorporates public domain text from [http://ghr.nlm.nih.gov The U.S. National Library of Medicine]'' | ''This article incorporates public domain text from [http://ghr.nlm.nih.gov The U.S. National Library of Medicine]'' | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] |
Latest revision as of 13:49, 2 December 2016
For patient information on this page, click here Template:DiseaseDisorder infobox
Alport syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Alport syndrome On the Web |
American Roentgen Ray Society Images of Alport syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Synonyms and keywords: Hereditary nephritis; hemorrhagic familial nephritis; X-linked nephropathy and deafness; hematuria-nephropathy-deafness; hereditary deafness and nephropathy
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Alport syndrome from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Echocardiography or Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
This article incorporates public domain text from The U.S. National Library of Medicine